Skip to main content

Month: September 2024

Intelligent Bio Solutions Inc. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results and Operational Highlights

– Fourth-quarter revenue of $0.73 million, up 64% year-over-year – – Full-year revenue of $3.11 million, up 148% year-over-year – – As of June 30, 2024, the Company had $6.30 million in cash – NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, announced its financial results for the fiscal fourth quarter and full-year ended June 30, 2024, and provided a business update. Fiscal fourth quarter revenue totalled $0.73 million, an increase of 64% compared to the same period the prior year, and full-year revenue totalled $3.11 million, an increase of 148% compared to the prior fiscal year. As of June 30, 2024, the Company had $6.30 million in cash. “Our...

Continue reading

Gevo, Inc. Announces Sale of Approximately $20 Million of Investment Tax Credits Generated by the Gevo NW Iowa RNG Facility Under Inflation Reduction Act, Helping to Drive Further Investment in Clean Energy

ENGLEWOOD, Colo., Sept. 19, 2024 (GLOBE NEWSWIRE) — Gevo, Inc. (NASDAQ: GEVO) is pleased to announce the sale of approximately $20 million in Investment Tax Credits to an undisclosed corporate buyer. This transaction monetizes Inflation Reduction Act (“IRA”) Investment Tax Credits generated from the commercialization of a renewable natural gas (“RNG”) production facility by Gevo NW Iowa RNG, LLC (“Gevo RNG”) and provides net cash proceeds of approximately $17 million to Gevo after transaction fees. The Gevo RNG asset has been optimized to produce approximately 400,000 MMBtus of RNG per year, and Gevo expects to further increase production over time. Additional RNG value could be unlocked through the monetization of Section 45Z Clean Fuel Production Credits under the IRA, once those rules are defined. Gevo RNG generates RNG by collecting...

Continue reading

LPL Financial welcomes Bury Financial Group

SAN DIEGO, Sept. 19, 2024 (GLOBE NEWSWIRE) — LPL Financial LLC, announced today that the advisors with Bury Financial Group have joined LPL Financial’s broker-dealer, RIA and custodial platforms. They reported having served approximately $655 million in advisory, brokerage and retirement plan assets* and join LPL from Osaic. President and Managing Partner Todd Bury founded the Youngstown, Ohio-based practice in 1992 while he was a sophomore in college. He earned his financial planning license by age 20 and steadily grew his client base, operating as a one-man shop for more than a decade. In 2006, Bury partnered with Vice President/ Managing Partner Brian Laraway, who shared his values and belief that clients are better served in a collaborative environment where each advisor brings a different skillset and background to the team. Together...

Continue reading

ECD Auto Design Launches Cars & Coffee Culture with Inaugural Event: Sunday, September 22, 2024 at Its Kissimmee, FL Headquarters

KISSIMMEE, Fla., Sept. 19, 2024 (GLOBE NEWSWIRE) — ECD Auto Design, a leader in custom, one-of-one luxury vehicle restorations, specializing in Land Rover Defenders, Range Rover Classics, Jaguar E-Types, Mustangs, and Toyota FJs is excited to announce the launch of its Cars & Coffee culture, beginning with an inaugural event on Sunday, September 22, 2024. From 9:00 AM to 12:00 PM, our ECD fan base of over 540,000, automotive enthusiasts, clients, content creators, and media partners are invited to experience firsthand the craftsmanship that has made ECD a standout in the industry. Not only will guests be able to see the vehicles, but they will also be invited to take tours of the impressive 100,000 square-foot facility where everything comes together. Taking place at the ECD headquarters in Kissimmee, Florida, this Cars &...

Continue reading

Personal Mobility Devices Market to Register CAGR of 6.8% by 2031 | SkyQuest Technology

Westford, USA, Sept. 19, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Global Personal Mobility Devices Market will reach a value of USD 19.13 Billion by 2031, with a CAGR of 6.8% during the forecast period (2024-2031).  Some of the factors that have contributed to the growth in the personal mobility device market include growing aging populations, urbanization, and increasing consumer awareness of problems dealing with accessibility and convenience. The market is increasingly developing with technologies such as long-life batteries and intelligent features, making mobility solutions more attractive and functional for a greater diversity of customers. Get a Free Sample Research Report:https://www.skyquestt.com/sample-request/personal-mobility-devices-market Segmentation Analysis: By Product Walking Aids, Rollators, Others...

Continue reading

Kaspi.kz receives first international credit rating

ALMATY, Kazakhstan, Sept. 19, 2024 (GLOBE NEWSWIRE) — Kaspi.kz has received its first international credit rating. Fitch rates Kaspi.kz investment grade BBB- with a stable outlook. This rating is separate from Kaspi Bank, a component of Kaspi.kz’s Fintech Platform, which has been tracked by international rating agencies for many years. Fitch also rates Kaspi Bank investment grade BBB- with a stable outlook. According to Fitch, the rating reflects Kaspi.kz’s unique business profile, leading nationwide franchise and one of the strongest levels of operating profitability when compared to peers globally. Among the key rating drivers are:Diverse business model: Kaspi.kz’s Super App business model is unique in its ability to successfully combine leading franchises across payments, commerce and fintech. Stellar profitability: Past earnings...

Continue reading

Form 8.3 – AXA INVESTMENT MANAGERS: Segro plc

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: AXA Investment Managers S.A.(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree SEGRO plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For an opening...

Continue reading

P10 Hosts Investor Day

DALLAS, Sept. 19, 2024 (GLOBE NEWSWIRE) — P10, Inc. (NYSE: PX) (the “Company”), a leading private markets solutions provider, will host an Investor Day in New York today, beginning at 8:30 a.m. Eastern Time. During the event, P10’s management team and strategy leadership will provide an in-depth presentation of the Company’s strategic vision, investment strategies, growth levers, and financial outlook. The formal presentations will be followed by a Q&A session, with the webcast portion of the event concluding by approximately 12:30 p.m. Eastern Time. The live webcast and supporting materials will be available through the following link: 2024 Investor Day. A replay will be made available following the conclusion of the event on Company’s investor relations page at www.p10alts.com. About P10P10 is a leading multi-asset class...

Continue reading

EDAP and Avenda Health Launch World’s First AI-Assisted Focal One® Robotic HIFU Procedures

                                                First Unfold AI®-Assisted Focal One procedures successfully performed at the UCLA School of Medicine FDA-cleared Unfold AI enables urologists to provide tailored, patient-specific Robotic HIFU ablation for prostate cancer patients EDAP and Avenda Health to present Unfold AI-Assisted Focal One simulated procedures at the 2024 Joint Meeting of the Focal Therapy Society & Society of Urologic Robotic Surgeons in Washington, DC September 19-21, 2024LYON, France, September 19, 2024 – EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, and Avenda Health (“Avenda”), a leading AI healthcare company, today announced a collaboration agreement for the purpose of offering personalized prostate cancer care, utilizing Avenda’s groundbreaking AI technology, Unfold...

Continue reading

Evaxion launches improved AI-Immunology™ platform for vaccine antigen prediction

The new version 5.0 of the AI model EDEN™ features a novel toxin antigen predictor, is trained on an expanded dataset and includes an advanced protein prediction feature The launch will expectedly improve Evaxion’s ability to fast and effectively discover AI-derived novel vaccines and is expected to further solidify the strong interest seen in AI-Immunology™ from potential partners New data demonstrating the improved performance of EDEN™ will be presented today at the European Conference on Computational Biology in Turku, FinlandCOPENHAGEN, Denmark, Sept. 19, 2024 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, launches an enhanced version of its clinically validated AI-Immunology™...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.